US 11389433
BRD4 inhibitor treatment of IgE-mediated diseases
granted A61KA61K31/438A61K45/06
Quick answer
US patent 11389433 (BRD4 inhibitor treatment of IgE-mediated diseases) held by The Board of Regents of the University of Texas System expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jul 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/438, A61K45/06